Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 20, 2016

Primary Completion Date

July 18, 2020

Study Completion Date

July 18, 2020

Conditions
Ovarian CancerFallopian Tube CancerPeritoneal CancerOvarian DiseasesFallopian Tube DiseasesPeritoneal Diseases
Interventions
PROCEDURE

Baseline Biopsy

Baseline biopsy (and ascites fluid sampling if applicable). This is done during the normal work-up procedures.

PROCEDURE

Tissue Collection

Tissue collection during debulking surgery.

PROCEDURE

Blood Draws

Blood samples for paclitaxel and carboplatin plasma levels will be collected in the study. Paclitaxel will be measured on cycle 1 day 1 at predose and then at the end of the infusion, followed by 1, 2, 4, 8 hours after the end of infusion, then on cycle 1 day 2 at 24 hours after the end of infusion. Carboplatin will be sampled for on cycle 1 day 1 at predose and then at the end of the infusion, followed by 0.5, 1.5, 3.5, 7.5 hours after the end of infusion, then on cycle 1 day 2 at 23.5 hours after the end of infusion.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
collaborator

The V Foundation for Cancer Research

OTHER

collaborator

Kay Yow Cancer Fund

UNKNOWN

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT02973750 - Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer | Biotech Hunter | Biotech Hunter